Brown Advisory
MRNA icon

Brown Advisory’s Moderna MRNA Stock Holding History

Brown Advisory’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$678K Sell
13,344
-749
-5% -$34.9K ﹤0.01% 966
2025
Q4 		$416K Buy
14,093
+29
+0.2% +$788 ﹤0.01% 1117
2025
Q3 		$363K Buy
14,064
+6,425
+84% +$179K ﹤0.01% 1145
2025
Q2 		$211K Sell
7,639
-6,441
-46% -$170K ﹤0.01% 1282
2025
Q1 		$399K Buy
14,080
+6,755
+92% +$240K ﹤0.01% 1052
2024
Q4 		$305K Sell
7,325
-772
-10% -$36.9K ﹤0.01% 1150
2024
Q3 		$541K Sell
8,097
-477
-6% -$43.8K ﹤0.01% 980
2024
Q2 		$1.02M Buy
8,574
+1,124
+15% +$142K ﹤0.01% 769
2024
Q1 		$794K Buy
7,450
+1,687
+29% +$170K ﹤0.01% 833
2023
Q4 		$573K Sell
5,763
-379
-6% -$31.9K ﹤0.01% 901
2023
Q3 		$634K Buy
6,142
+2,880
+88% +$321K ﹤0.01% 852
2023
Q2 		$396K Buy
3,262
+58
+2% +$7.74K ﹤0.01% 956
2023
Q1 		$492K Buy
3,204
+207
+7% +$34.1K ﹤0.01% 911
2022
Q4 		$538K Sell
2,997
-186
-6% -$30.4K ﹤0.01% 893
2022
Q3 		$376K Buy
3,183
+481
+18% +$73K ﹤0.01% 923
2022
Q2 		$386K Buy
2,702
+49
+2% +$7K ﹤0.01% 903
2022
Q1 		$457K Buy
2,653
+317
+14% +$53.4K ﹤0.01% 879
2021
Q4 		$593K Sell
2,336
-10
-0.4% -$2.92K ﹤0.01% 834
2021
Q3 		$903K Sell
2,346
-63
-3% -$23.2K ﹤0.01% 712
2021
Q2 		$566K Buy
2,409
+246
+11% +$44K ﹤0.01% 816
2021
Q1 		$283K Buy
+2,163
New +$313K ﹤0.01% 958

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory's MRNA Position: Q1 2026 in Review

Brown Advisory reduced its Moderna (MRNA) stake by 5.3% in Q1 2026, selling an estimated $34.9K and leaving 13,344 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #966.

Brown Advisory first reported a position in MRNA in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.02M in Q2 2024. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Brown Advisory held 13,344 shares of Moderna worth $678K as of Q1 2026.
  • Brown Advisory sold 749 Moderna shares in Q1 2026, an estimated $34.9K.
  • Moderna made up ﹤0.01% of Brown Advisory's portfolio in Q1 2026, its #966 holding.
  • Brown Advisory first reported a position in Moderna in Q1 2021 and has held it in 21 quarters since.
  • Brown Advisory's Moderna position peaked at $1.02M in Q2 2024.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.